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A 51-year-old Caucasian woman with Listeria monocytogenesmeningitis was treated and discharged after an uncomplicated course.
Her medical history included immunosuppressive treatment with prednisolone and azathioprine for autoimmune hepatitis. A
diagnostic work-up after the meningitis episode revealed that she had low levels of the IgG4 subclass. To our knowledge, this is the
first case report describing a possible association between autoimmune hepatitis and the occurrence of Listeria monocytogenes
meningitis, describing a possible association between Listeria monocytogenes meningitis and deficiency of the IgG4 subclass
and finally describing a possible association between Listeria monocytogenes meningitis and immunosuppressive therapy with
prednisolone and azathioprine.
1. Introduction
Listeria monocytogenes is a pathogen associated with menin-
gitis and/or sepsis [1, 2]. It is well known that cases of invasive
infections with Listeria monocytogenes are often associated
with different states of immunosuppression and pregnancy,
and with severe comorbidity like cancer [3–6]. Our case
report is pointing towards three possible associations with
invasive listeria infection: autoimmune hepatitis, treatment
with prednisolone and azathioprine, and finally low levels of
IgG4 subclass immunoglobulins.
2. Case Presentation
A 51-year-old Caucasian female, treated in the Hepatology
Out-Patient Clinic with oral prednisolone 5mg daily and
oral azathioprine 100mg daily for an autoimmune hepatitis
since 2006, was admitted to the Medical Department at the
National Hospital, Faroe Islands, in 2013, after only 12 hours
with evolving headache, vomiting, and fever. At admission,
the Glasgow Coma Scale (GCS) was 15 points, temperature
38.9 degrees Celsius, blood pressure 126/73, heart rate 85, and
oxygen saturation 93%. No neck stiffness and no neurological
deficits were found. Blood chemistry at the time of admission
showed an elevated C-reactive protein (CRP) of only 13mg/L.
A CT of the brain without contrast and a chest X-ray were
performedwith no abnormalities. Blood cultures were drawn
before administration of antibiotics. Because the patient had
been coughing for 3 weeks prior to the admission, intra-
venous benzylpenicillin 2MIU four times daily was started at
the time of admission, on suspicion of lower respiratory tract
infection. Within a few hours after admission, the patient
became somnolent with descending GCS and rising fever to
over 40 degrees Celsius. A spinal tap was performed and
a turbid cerebrospinal fluid (CSF) was sampled with pleo-
cytosis 1333 × 106/L, 78% neutrophils, CSF-protein 2.0 g/L,
andCSF-glucose 1.9mmol/L (blood glucose 6.0mmol/L). On
suspicion of meningitis and/or encephalitis, the patient was
switched over to intravenous benzylpenicillin 3MIU 6 times
daily combined with intravenous ceftriaxone 4 g daily and
also combined with intravenous aciclovir 750mg three times
daily. The patient was not given dexamethasone, because
she had received one dose of intravenous benzylpenicillin
2MIU prior to the spinal tap. Gram stain of the CSF was
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negative. CSF was sent to polymerase chain reaction (PCR)
examinations forHerpes simplex virus,Varicella-zoster virus,
Epstein-Barr virus, Cytomegalovirus, Mycoplasma pneumo-
niae, and Enterovirus, specific PCR for Streptococcus pneu-
moniae, and specific PCR forNeisseria meningitidis. All these
PCR examinations were negative. Blood cultures from the
time of admission showed no growth. On the second day
of admission, the Laboratory of Clinical Microbiology at
our hospital identified Gram positive rods from the CSF
cultures. On suspicion of possible infection with Listeria
monocytogenes, the antibiotical therapy was supplemented
with intravenous gentamicin 240mg daily. A CT of the brain
with contrast and anMRI of the brain with contrast ruled out
the presence of brain abscesses. During the next two days,
she improved clinically with rising GCS. On the fourth day
of admission, the Laboratory of Clinical Microbiology at our
hospital confirmed identification of Listeriamonocytogenes in
the CSF. The Listeria monocytogenes strain was as expected
sensitive to benzylpenicillin, ampicillin, and gentamicin.
Treatment with ceftriaxone and aciclovir was terminated.
She improved very fast and already on the fourth day she
was up walking on the ward with a GCS of 15 points. The
Listeriamonocytogenesmeningitis was treated for threeweeks
with high dose of benzylpenicillin, supplemented for the first
weekwith gentamicin.The azathioprine treatment was halted
during the admission, and after a few days of admission
the oral prednisolone treatment was changed to intravenous
hydrocortisone-succinat 100mg two times daily. She had a
flare-up in the level of her liver enzymes after two weeks of
admission and she was switched back to oral prednisolone,
starting out with a dose of 25mg daily, but still pausing
her azathioprine treatment. After three weeks of antibiotic
treatment for Listeria monocytogenes, she was released from
hospital. Seven months after the hospital stay, she was started
again on her usual oral azathioprine 100mg daily treatment
combined with oral prednisolone 15mg daily. A diagnostic
work-up for immunodeficiencies was done and revealed a
low IgG4 subclass 0.005–0.017 g/L (reference values 0.052–
1.25 g/L). The IgG subclasses have been analyzed four times
since her episode with Listeria monocytogenes meningitis
(Table 1). Until now she has been clinically stable and she is
followed up on a regular basis in both the Hepatology and
the Infectious Diseases/Immune Defect Out-Patient Clinics
at the National Hospital, Faroe Islands. She is still treated
with azathioprine and prednisolone in the same dosages.
She has not had any serious infections since her Listeria
monocytogenesmeningitis and she is living well.
3. Discussion
Listeria monocytogenesmeningitis and/or sepsis is associated
with the extreme of ages, immunosuppression, comorbidity,
and pregnancy [1–7]. It is a very rare diseasewith an estimated
incidence of 0.05–0.2 cases/100.000 population/yrs [8, 9].
The mortality rate is approx. 17–25% [1, 6, 10]. Ampicillin,
amoxicillin, and benzylpenicillin are considered to be the
treatment of choice for Listeria monocytogenes meningitis
[1, 2, 6, 7]. A large recent multinational retrospective cohort
study examined clinical features, diagnosis, treatment, and
prognosis in neuroinfectionswith Listeriamonocytogenes [6].
In this study, addition of aminoglycoside therapy did not
affect the prognosis in neuroinfectionwith Listeriamonocyto-
genes [6]. Delay in relevant antimicrobial treatment covering
for Listeria monocytogenes and the presence of seizures were
associated with increased mortality in this study [6].
Autoimmune hepatitis is an autoimmune disease involv-
ing the liver [11]. The disease is often well treated with
prednisolone alone or combination treatment with aza-
thioprine [11]. The incidence of autoimmune hepatitis has
been reported to be 1.68/100.000 population/yrs in Denmark
[12]. The patient in this case report was diagnosed with
autoimmune hepatitis in 2006. At the time of admission
with Listeria monocytogenesmeningitis, she had been treated
with prednisolone 5mg daily and azathioprine 100mg daily
for several years, and she was clinically stable regarding her
autoimmune hepatitis. To our best knowledge, no case has
been published describing Listeria monocytogenesmeningitis
in a patient with autoimmune hepatitis and this is the
first report with this combination of diseases. There is no
convincing evidence in the literature associating autoim-
mune hepatitis with an increased risk of serious infections,
independently of immunosuppressive drugs used to treat
autoimmune hepatitis. However such a direct effect of the dis-
ease autoimmune hepatitis would be difficult to demonstrate,
because most patients are treated with either prednisolone
or prednisolone and azathioprine in combination. In other
autoimmune diseases like systemic lupus erythematosus,
there are data indicating an increased risk of infection
independent of immunosuppressive treatment [13].
An increased risk of severe invasive infections and oppor-
tunistic infections is well documented in association with
treatment with immunosuppressive drugs like prednisolone,
azathioprine, tumour-necrosis-factor inhibitors (TNF-in),
and other potent immunosuppressive drugs [14, 15]. TNF-
in have been reported increasingly to be associated with
different severe infections and opportunistic infections in
patients treated with these potent immunosuppressive drugs
[16]. More than 15 reports on cases of Listeria monocytogenes
infection after treatment with TNF-in have been made [17].
In many of those cases, patients were also treated with other
immunosuppressive drugs like prednisolone and azathio-
prine [17]. One report described occurrence of Listeriamono-
cytogenes sepsis in a patient with ulcerative colitis treated
with combination of prednisolone and azathioprine like in
our patient [18]. Two reports described occurrence of Listeria
monocytogenes in patients with ulcerative colitis treated with
monotherapy of azathioprine [19–21]. Only one previous
case with Listeria monocytogenes occurring in a patient with
autoimmune hepatitis has been published [22]. This was
spontaneous bacterial peritonitis withListeriamonocytogenes
in a patient with liver cirrhosis, ascites, and autoimmune
hepatitis treated with azathioprine [20, 21]. Our patient was
treated with both prednisolone and azathioprine, so it is
impossible to conclude which of those two immunosuppres-
sive drugs had a main role in facilitating the development of
Listeria monocytogenesmeningitis in our patient. A synergis-
tic negative role between prednisolone and azathioprine in
our patient cannot be excluded. The role of her autoimmune
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Table 1: Levels of immunoglobulins and subclasses.
Immunoglobulin reference values January 2013 February 2013 September 2013 December 2014
IgG (total) g/L
6.4–13.5 g/L 9.8 11.0 12.3 12.1
IgA (total) g/L
0.7–3.12 g/L 1.95 2.63 2.90 2.58
IgM (total) g/L
0.56–3.52 2.80 4.22 5.11 3.73
IgG1 g/L
2.8–8 g/L 6.9 7.9 8.1 8.4
IgG2 g/L
1.2–5.7 g/L 2.18 2.52 2.92 2.89
IgG3 g/L
0.24–1.25 g/L 1.780 1.710 2.030 1.720
IgG4 g/L
0.052–1.25 g/L 0.006
a 0.017b 0.005 0.015
aSample from the third day of admission.
bSample from 4 weeks after admission day.
hepatitis independently of the immunosuppressive drugs
cannot be estimated. An immunological animal study on
mice examining the negative effect on the immune system
in coping infection with Listeria monocytogenes, when the
immune system is exposed either to cyclophosphamide,
vinblastine, and azathioprine or to methotrexate, indicated a
substantial long-term negative effect of azathioprine on the
immune response regarding infection with Listeria monocy-
togenes [23].
In a diagnostic and immunological work-up looking for
other causes for this unusual infection in our patient with
autoimmune hepatitis, we observed relative low levels of IgG4
subclass in screening of her immunoglobulin levels and her
subclass IgG levels. A screening program for immune defi-
ciencies in patients with neuroinfections has been done since
2011 at our department. All patients with life-threatening
neuroinfections have been screened with measurements of
immunoglobulins including IgG subclasses and flow cyto-
metric analyses of lymphocyte subsets. That was the reason
for measuring immunoglobulins in our patient presented in
this report.The knowledge about the significance of low levels
of IgG subclasses is still pending [24]. The most common
IgG subclass deficiency is low levels of IgG2 combined with
low levels of IgA [25]. IgG4 deficiencies are not common and
the role of low levels of IgG4 has not been understood yet.
Reports have been published showing that IgG4 deficiency
can be a monodeficiency but can also occur with low levels
of IgG2, IgA, and/or IgG1 [24, 25]. Deficiencies of IgG4 have
been connected to different infections and autoimmune dis-
orders; however data are scarce [26]. To our knowledge, this is
the first report documenting presence of IgG4 deficiency and
at the same time the combination of autoimmune hepatitis
and Listeria monocytogenes meningitis. However, the role of
this deficiency of IgG4 is pending. Several studies indicate
that the treatment with prednisolone and azathioprine is
probably not influencing the levels of IgG subclasses [27, 28].
This could indicate that the low IgG4 levels in our patient
were independent of the immunosuppressive treatment with
prednisolone and azathioprine, and therefore it could be
speculated that our patient had an IgG4 deficiency immune
defect that could have a role in the occurrence of Listeria
monocytogenes meningitis. It is well known that levels of
immunoglobulins including IgG subclasses can fluctuate
significantly relating to active infection, operation, and other
causes [25]. Therefore, measurements of IgG subclasses have
to be repeated to come to a conclusion.The patient described
in this report had also slightly elevated IgM and IgG3
subclasses and this can be explained by the autoimmune
hepatitis where elevated levels of IgG and subclasses are seen
[11].
In conclusion, we present the first case in the literature
with the combination of Listeria monocytogenes meningi-
tis and autoimmune hepatitis. Our report points towards
three possible associations with the development of Liste-
ria monocytogenes meningitis: her autoimmune hepatitis in
itself; immunosuppressive treatment with prednisolone and
azathioprine; and finally her IgG4 subclass deficiency.
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